A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)
Lorenzo Villa Zapata, Ainhoa Gómez-Lumbreras, John R. Horn, Malinda Tan, Richard D. Boyce, Daniel C. Malone
Topics & Concepts
TizanidineMedicineAdverse Event Reporting SystemAdverse effectPharmacologyAnesthesiaInternal medicineSpasticityPharmacogenetics and Drug MetabolismPharmacovigilance and Adverse Drug ReactionsDrug-Induced Adverse Reactions